Crispr Therapeutics Ag Common Shares (CRSP)

$ 57.99
   
  • Change Today:
    $-0.20
  • 52 Week High: $76.78
  • 52 Week Low: $32.38
  • Currency: US Dollars
  • Shares Issued: 47.19m
  • Volume: 1,140
  • Market Cap: $2,736.71m
  • RiskGrade: 311

CRSP Overview

1 Day Chart (07-01-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

CRSP Fundamentals

Fundamentals data is not available for this company.

CRSP Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 111.08 (442.66) (407.88)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 277.74 (353.22) (348.03)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

CRSP ShareCast News

MaxCyte signs cell platform deal with CRISPR and... 14-Mar-2017 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

CRSP Market Data

Currency US Dollars
Share Price $ 57.99
Change Today $ -0.20
% Change -0.34 %
52 Week High $76.78
52 Week Low $32.38
Volume 1,140
Shares Issued 47.19m
Market Cap $2,736.71m
RiskGrade 311

What The Brokers Say

Strong Buy 6
Buy 10
Neutral 11
Sell 2
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page